XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.510
-0.050 (-1.95%)
Oct 14, 2025, 4:00 PM EDT - Market closed
XBiotech Market Cap
XBiotech has a market cap or net worth of $76.52 million as of October 15, 2025. Its market cap has decreased by -65.15% in one year.
Market Cap
76.52M
Enterprise Value
-76.41M
1-Year Change
-65.15%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $76.52M, a decrease of -89.62%. That is a compound annual growth rate of -19.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 76.50M | -36.46% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |